当前位置: 首页 >> 检索结果
共有 5422 条符合本次的查询结果, 用时 7.666598 秒

61. WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults.

作者: Mohammad Kazem Fallahzadeh.;Krista Lentine.;Neeraj Singh.
来源: JAMA. 2026年

63. The Geography of Pharmaceutical Innovation: The US and China in a New World Order.

作者: Richard Pazdur.;Steven Usdin.
来源: JAMA. 2026年

64. The Language of Loss.

作者: Caroline P Meehan.
来源: JAMA. 2026年

65. WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults.

作者: Daniela Dellepiane.;Maurizio Fadda.;Daniela Ojeda Mercado.
来源: JAMA. 2026年

66. WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults.

作者: Patrick Redmond.
来源: JAMA. 2026年

67. Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood-Reply.

作者: Brandon K Bellows.;Sarah D de Ferranti.;Andrew E Moran.
来源: JAMA. 2026年

68. When Rare Is Common-Rethinking Pediatric Genetic Care.

作者: Harry Ostrer.
来源: JAMA. 2026年

69. Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

作者: Krisjon Olson.;Jessica Cao.;Amy L Peterson.
来源: JAMA. 2026年

70. The Oncology Care Model and Medicare Payments, Utilization, and Quality.

作者: Gabriel A Brooks.;Matthew Trombley.;Sean McClellan.;Qing Zheng.;Mary Beth Landrum.;Van Doren Hsu.;Colleen M Kummet.;Pang-Hsiang Liu.;Derek Hoodin.;Colin Doyle.;Carol Simon.;Nancy L Keating.
来源: JAMA. 2026年
The Oncology Care Model (OCM) was the Centers for Medicare & Medicaid Services' first cancer-focused alternative payment model, running from 2016 to 2022. The OCM aimed to reduce Medicare spending and improve quality of care for patients receiving chemotherapy.

71. Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

作者: Joseph Burns.;Stephen Daniels.;Justin P Zachariah.
来源: JAMA. 2026年

72. Rewriting the Narrative on the Oncology Care Model.

作者: Ravi B Parikh.;Stephen M Schleicher.;Samyukta Mullangi.
来源: JAMA. 2026年

73. National Prescribing Trends of Direct-Acting Antivirals for Hepatitis C.

作者: Sanjay Kishore.;Margaret Hayden.;Micah Johnson.;Aaron S Kesselheim.;Benjamin N Rome.
来源: JAMA. 2026年

74. Embracing Bayesian Methods in Clinical Trials: FDA's Long-Awaited Draft Guidance.

作者: J Jack Lee.;Frank E Harrell.;Lisa M LaVange.;David J Spiegelhalter.
来源: JAMA. 2026年

75. FDA Draft Guidance for the Use of Bayesian Methods in Clinical Trials.

作者: Andrew Gelman.;Erik van Zwet.;Witold Wiecek.
来源: JAMA. 2026年

76. Sodium Bicarbonate Infusion for Severe Metabolic Acidemia and Acute Kidney Injury-Reply.

作者: Boris Jung.;Nicolas Molinari.;Samir Jaber.
来源: JAMA. 2026年

77. Sodium Bicarbonate Infusion for Severe Metabolic Acidemia and Acute Kidney Injury.

作者: Kanako Fukushima.;Masahiro Kashiura.;Takashi Moriya.
来源: JAMA. 2026年

78. Diagnosis and Management of Resistant Hypertension: A Review.

作者: Michel Azizi.;Wanpen Vongpatanasin.;Naomi D L Fisher.;Felix Mahfoud.;Laurence Amar.;Ajay J Kirtane.
来源: JAMA. 2026年
Hypertension, defined as office systolic blood pressure (SBP) 130 mm Hg or greater and/or diastolic blood pressure 80 mm Hg or greater, affects 43.9% of women and 49.5% of men in the US. Approximately 19.7% of patients treated for hypertension have apparent resistant hypertension (blood pressure ≥130/80 mm Hg) despite using 3 or more antihypertensive medications, preferably a renin-angiotensin system blocker, a calcium channel blocker, and a thiazide-type diuretic, at maximally tolerated doses.

79. Opportunity for Improved Menopausal Hormone Therapy Prescribing.

作者: Deborah Bartz.;Ananya Tadikonda.;JoAnn E Manson.
来源: JAMA. 2026年

80. Management of Hypertension in Adults.

作者: Amber E Johnson.;Christopher D Jackson.;Jason T Alexander.
来源: JAMA. 2026年
共有 5422 条符合本次的查询结果, 用时 7.666598 秒